COcoa Supplement and Multivitamin Outcomes Study

PHASE4CompletedINTERVENTIONAL
Enrollment

21,442

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2022

Study Completion Date

June 5, 2023

Conditions
Cardiovascular DiseaseCancer
Interventions
DIETARY_SUPPLEMENT

Cocoa extract

2 capsules each day containing a total of 500 mg cocoa flavanols, including 80 mg (-)-epicatechin, and 50 mg theobromine

DIETARY_SUPPLEMENT

Multivitamin

Multivitamin

DIETARY_SUPPLEMENT

Cocoa extract placebo

Cocoa extract placebo

DIETARY_SUPPLEMENT

Multivitamin placebo

Multivitamin placebo

Trial Locations (2)

98109

Fred Hutchinson Cancer Research Center, Seattle

02215

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Fred Hutchinson Cancer Center

OTHER

collaborator

Mars, Inc.

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT02422745 - COcoa Supplement and Multivitamin Outcomes Study | Biotech Hunter | Biotech Hunter